The Lancet Rheumatology : Impact Factor & More
eISSN: 2665-9913pISSN: 2665-9913
Share this on:
Key Metrics
CiteScore 
23
Eigenfactor
< 0.001
Impact Factor
5 - 10
Scite Index
0.89 5-Year SI
SJR
Q1Immunology
SNIP
5.68
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on The Lancet Rheumatology
The Lancet Rheumatology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2019 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet Rheumatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet Rheumatology
Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.
- 3 Aug 2026
- The Lancet. Rheumatology
BMI as a modifier of Janus kinase inhibitor response in rheumatoid arthritis.
- 3 Aug 2026
- The Lancet. Rheumatology
The end for avacopan.
- 1 Aug 2026
- The Lancet. Rheumatology
The role of health literacy in clinical, treatment, and work-related outcomes in people with inflammatory arthritis in England: a cross-sectional study.
- 1 Aug 2026
- The Lancet. Rheumatology
Re-evaluating anti-AT1A1 for predicting fetal atrioventricular block in anti-SSA/Ro positive pregnancies.
- 1 Aug 2026
- The Lancet. Rheumatology
Beyond MRI positivity in axial spondyloarthritis: the ubiquity of bone marrow oedema and risk of overinterpretation.
- 1 Aug 2026
- The Lancet. Rheumatology
Impact of BMI on response to Janus kinase inhibitors in rheumatoid arthritis: an individual patient data meta-analysis of randomised controlled trials.
- 3 Aug 2026
- The Lancet. Rheumatology
BMI as a modifier of Janus kinase inhibitor response in rheumatoid arthritis.
- 3 Aug 2026
- The Lancet. Rheumatology
The end for avacopan.
- 1 Aug 2026
- The Lancet. Rheumatology
The role of health literacy in clinical, treatment, and work-related outcomes in people with inflammatory arthritis in England: a cross-sectional study.
- 1 Aug 2026
- The Lancet. Rheumatology
Re-evaluating anti-AT1A1 for predicting fetal atrioventricular block in anti-SSA/Ro positive pregnancies.
- 1 Aug 2026
- The Lancet. Rheumatology
Beyond MRI positivity in axial spondyloarthritis: the ubiquity of bone marrow oedema and risk of overinterpretation.
- 1 Aug 2026
- The Lancet. Rheumatology
FAQs on The Lancet Rheumatology
How long has The Lancet Rheumatology been actively publishing? 
What is the publishing frequency of The Lancet Rheumatology?
How many articles did The Lancet Rheumatology publish last year?
What is the eISSN & pISSN for The Lancet Rheumatology?
What is Citescore for The Lancet Rheumatology?
What is SNIP score for The Lancet Rheumatology?
What is the SJR for The Lancet Rheumatology?
Who is the publisher of The Lancet Rheumatology?
